Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Patients Rivaroxaban'

Patients Rivaroxaban published presentations and documents on DocSlides.

Rivaroxaban or Aspirin for Extended Treatment of Venous Thr

Rivaroxaban or Aspirin for Extended Treatment of Venous Thr

  • yoshiko-marsland
  • 25 Slides

(EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS....

Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease:

Rivaroxaban Plus Aspirin in Patients With and Without Heart Failure and Chronic Coronary or Peripheral Artery Disease:

  • giovanna-bartolotta
  • 15 Slides

Rivaroxaban Plus Aspirin in Patients With and Wit...

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban

A Multicenter Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban

  • celsa-spraggs
  • 0 Slides

Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...

Rivaroxaban compared with enoxaparin for the prevention of

Rivaroxaban compared with enoxaparin for the prevention of

  • luanne-stotts
  • 21 Slides

Alexander T Cohen . On behalf of the MAGELLAN Ste...

R eal-world

R eal-world

  • liane-varnes
  • 20 Slides

EVI. dence. on . S. troke prevention . I. n pati...

Review on NOACs Studies Dr.

Review on NOACs Studies Dr.

  • BlessedBeyondMeasure
  • 37 Slides

Kourosh. . Sadeghi. Tehran University of medical ...

A New Era in Anticoagulation Management

A New Era in Anticoagulation Management

  • debby-jeon
  • 46 Slides

Allyson Sarigianis, Pharm.D.. October 19, 2013. O...

Novel Oral Anticoagulants

Novel Oral Anticoagulants

  • natalia-silvester
  • 88 Slides

(. N. OAC). Dan . Moellentin. , . PharmD. , BCPS,...

A Multicenter Randomized Trial Evaluating Clinically Signif

A Multicenter Randomized Trial Evaluating Clinically Signif

  • ellena-manuel
  • 20 Slides

Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...

A Multicenter Randomized Trial Evaluating Clinically Signif

A Multicenter Randomized Trial Evaluating Clinically Signif

  • giovanna-bartolotta
  • 20 Slides

Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...

A New Era in Anticoagulation Management

A New Era in Anticoagulation Management

  • alexa-scheidler
  • 0 Slides

Allyson Sarigianis, Pharm.D.. October 19, 2013. O...

Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators

Dr. Phil Wells on behalf of the EINSTEIN CHOICE Steering Committee and Investigators

  • yoshiko-marsland
  • 18 Slides

Dr. Phil Wells on behalf of the EINSTEIN CHOICE ...

A ssessment of D ual antiplatelet therapy versus

A ssessment of D ual antiplatelet therapy versus

  • coursion
  • 22 Slides

R. ivaroxaban . I. n atrial . F. ibrillation patie...

MAGELLAN Primary efficacy endpoint at 10 days (DVT, symptomatic PE,

MAGELLAN Primary efficacy endpoint at 10 days (DVT, symptomatic PE,

  • HoneyBun
  • 1 Slides

VTE death. ) for . rivaroxaban. vs. . enoxaparin....

Reversing Course: Managing Anticoagulation and Antiplatelet Bleeding

Reversing Course: Managing Anticoagulation and Antiplatelet Bleeding

  • kyle585
  • 20 Slides

Paul P. . Dobesh. , . Pharm.D. , FCCP, BCPS, BCCP....

Recent ACS: STEMI, NSTEMI, UA

Recent ACS: STEMI, NSTEMI, UA

  • danika-pritchard
  • 20 Slides

Stabilized 1-7 Days Post-Index Event. Exclusions:...

New Oral Anticoagulant

New Oral Anticoagulant

  • mitsue-stanley
  • 80 Slides

R2 Patcharee Seesongsom. R2 . Sirada. . Phoja...

Stroke, Bleeding, and

Stroke, Bleeding, and

  • lois-ondreau
  • 7 Slides

Mortality Risks . in . Elderly Medicare Beneficia...

CAD/PAD in Primary Care CV Risk in Stable Outpatients

CAD/PAD in Primary Care CV Risk in Stable Outpatients

  • stefany-barnette
  • 0 Slides

Stratified by Baseline CV Risk Category. Aspirin ...

A ssessment of D ual antiplatelet therapy versus

A ssessment of D ual antiplatelet therapy versus

  • stefany-barnette
  • 22 Slides

A ssessment of D ual antiplatelet therapy versus...

Ima A. Kusuma , MD, FIHA

Ima A. Kusuma , MD, FIHA

  • hirook
  • 33 Slides

“JIH. ” Hospital, Yogyakarta, Indonesia. The U...

Rivaroxaban in stable peripheral or carotid artery disease

Rivaroxaban in stable peripheral or carotid artery disease

  • basidell
  • 17 Slides

Sonia Anand, on . behalf of the COMPASS Steering C...

Thromboembolic protocols

Thromboembolic protocols

  • cecilia
  • 27 Slides

& safe anticoagulant prescribing. July 2020. D...

X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the

X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the

  • LittleMissPerfect
  • 1 Slides

rivaroxaban. group vs. 1.02% of the vitamin K ant...

Bleeding and cancer risk in patients with vascular

Bleeding and cancer risk in patients with vascular

  • danika-pritchard
  • 17 Slides

Bleeding and cancer risk in patients with vascul...

P erioperative management of anticoagulated geriatric patients with

P erioperative management of anticoagulated geriatric patients with

  • TinyTeddy
  • 20 Slides

hip fractures. Dr Linda Xu . linda.xu@health.nsw.g...

Dodson Thompson, DO

Dodson Thompson, DO

  • lois-ondreau
  • 40 Slides

Northlakes. Community Clinic. Minong, WI. Novel ...

Pharmaceutical Management of Cardiac Medications:

Pharmaceutical Management of Cardiac Medications:

  • pamella-moone
  • 0 Slides

A Look at New Oral Anticoagulants. Linda Wing, . ...

Rapid Reversal of Anticoagulation for Patients with Intracerebral Hemorrhage

Rapid Reversal of Anticoagulation for Patients with Intracerebral Hemorrhage

  • faustina-dinatale
  • 0 Slides

Fred V. Plapp MD PhD. Pathology and Laboratory Me...

Management of Anticoagulant-Related Major Bleeding: Clinical Updates and Best Practices for Health-

Management of Anticoagulant-Related Major Bleeding: Clinical Updates and Best Practices for Health-

  • melanie
  • 108 Slides

Provided by ProCE, LLC and supported by an educati...

DentalUpdateNovember 2015A New Generation of Antiplatelet and Anticoag

DentalUpdateNovember 2015A New Generation of Antiplatelet and Anticoag

  • cecilia
  • 9 Slides

Steven Johnston, BDS, MSc, MFDS RCS(Ed), Dental Of...

28 th August 2022 Ganesan Karthikeyan, Stuart Connolly*,

28 th August 2022 Ganesan Karthikeyan, Stuart Connolly*,

  • dorothy
  • 15 Slides

Mpiko. . Ntsekhe. , Bongani . Mayosi. * and Salim...

Abbreviations: AF: atrial fibrillation, ACS: acute coronary syndrome, BD: twice daily, CAD: corona

Abbreviations: AF: atrial fibrillation, ACS: acute coronary syndrome, BD: twice daily, CAD: corona

  • holly
  • 17 Slides

CrCl. : creatinine clearance, CTO: chronic total o...

Update on the New Oral Anticoagulants

Update on the New Oral Anticoagulants

  • sherrill-nordquist
  • 39 Slides

Eliot Williams, MD PhD. Division of Hematology &a...

Management of

Management of

  • marina-yarberry
  • 74 Slides

Atrial. Fibrillation. Phillip H. Lam, M.D.. Chie...

Update in the Perioperative and Emergency Management of Nov

Update in the Perioperative and Emergency Management of Nov

  • danika-pritchard
  • 47 Slides

Annelise Gallien, MD FRCPC. Moncton City Hospital...

Anticoagulation and Thrombosis Management

Anticoagulation and Thrombosis Management

  • pasty-toler
  • 14 Slides

Anticoagulation and Thrombosis Management A Revie...

Safe and Effective Use of Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know

Safe and Effective Use of Novel Oral Anticoagulants for Atrial Fibrillation: What You Need to Know

  • dsuser1
  • 64 Slides

Christopher Granger, . MD. Sean Pokorney, MD. . D...

The thick and thin of it: Reviewing Anticoagulant Options

The thick and thin of it: Reviewing Anticoagulant Options

  • oneill
  • 26 Slides

Lanae Fox, . PharmD. , BCPS. I have no financial d...

Spotlight Case New Oral Anticoagulants

Spotlight Case New Oral Anticoagulants

  • skylar
  • 24 Slides

This presentation is based on the . December 2013....

Copyright © 2024 DocSlides. All Rights Reserved